IP Library Granted Patent US 10,858,402
Granted Patent B2
US 10,858,402 · App. 16/736,505 · Granted Dec 8, 2020

Synthetic multiphase systems

Inventors: Cait Macphee (Edinburgh, GB); Nicola Stanley-Wall (Dundee, GB); Keith Bromley (Edinburgh, GB); Ryan Morris (Edingburgh, GB); Laura Hobley (Dundee, GB)
Assignee: The University Court of the University of Edinburgh
C07K14/32A23G9/38A23G9/46A23P30/40A61K8/046A61K8/06A61K8/11A61K8/64A61K9/107A61K9/122A61K9/5052A61K47/42A23V2002/00A23V2200/222A23V2200/226C07K2319/23
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,858,402
App. No.
16/736,505
Granted
Dec 8, 2020
Kind
B2
Abstract

A synthetic multiphase product including an isolated biofilm surface layer protein A (BslA), wherein the BslA has the amino acid sequence set forth in SEQ ID NO: 28 or a variant thereof that is at least 80% identical to SEQ ID NO: 28.

Claims (8)

1. A synthetic multiphase product comprising from 0.005 to 0.2 wt % of an isolated biofilm surface layer protein A (BslA), wherein the BslA has the amino acid sequence set forth in SEQ ID NO: 28 or an amino acid sequence that is at least 80% identical to SEQ ID NO: 28, and wherein the synthetic multiphase product further comprises at least one co-surfactant.

2. The synthetic multiphase product of claim 1 , wherein the synthetic multiphase product is a multiphase food product.

3. The synthetic multiphase product of claim 1 , wherein the synthetic multiphase product is a personal care product.

4. The synthetic multiphase product of claim 1 comprising at least three or more intimately mixed phases of matter.

5. The synthetic multiphase product of claim 4 , wherein the synthetic multiphase product comprises a pharmaceutical active agent.

6. A frozen synthetic multiphase product comprising from 0.005 to 0.2 wt % of an isolated BslA, wherein the BslA has the amino acid sequence set forth in SEQ ID NO: 28 or a variant thereof that is at least 80% identical to SEQ ID NO: 28, and wherein the synthetic multiphase product further comprises at least one co-surfactant.

7. The frozen synthetic multiphase product of claim 6 , wherein the at least one co-surfactant is a protein surfactant.

8. The frozen synthetic multiphase product of claim 6 comprising one or more additional components, wherein the one or more additional components comprises one or more of milk proteins, sugars, carbohydrates, egg proteins and fats.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2020
From: STANLEY-WALL, NICOLA
To: THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH
Reel/Frame 054166/0123 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2020
From: MACPHEE, CAIT
To: THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH
Reel/Frame 054207/0236 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2020
From: BROMLEY, KEITH
To: THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH
Reel/Frame 054207/0240 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2020
From: MORRIS, RYAN
To: THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH
Reel/Frame 054207/0370 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2020
From: HOBLEY, LAURA
To: THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH
Reel/Frame 054207/0401 →
Priority Claims (2)
GB 14147632.6 · Aug 19, 2014 · national
GB 1511724.5 · Jul 3, 2015 · national
Continuity (2)
Division 15504925
Related Publication 20200207813A1 · Jul 2, 2020